ライフサイエンスコーパス: hematopoietic disorder

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ntial role in EpoR-JAK2 V617F mutant-induced hematopoietic disorder.

2 at STAT5 is critical for JAK2 mutant-induced hematopoietic disorder.

3 us for blood cell formation in patients with hematopoietic disorders.

4 g the molecular aspects of hematopoiesis and hematopoietic disorders.

5 oietic system as well as for gene therapy of hematopoietic disorders.

6 as a target of gene transfer for therapy of hematopoietic disorders.

7 understanding and ameliorating skeletal and hematopoietic disorders.

8 tion program that result in various types of hematopoietic disorders.

9 lodysplastic syndromes (MDSs) are a group of hematopoietic disorders affecting the myeloid lineage, c

10 in this study would be therapeutic for many hematopoietic disorders and are supportive of a clinical

11 and when inappropriately activated can cause hematopoietic disorders and oncogenesis.

12 to the molecular biology of several cancers, hematopoietic disorders, and diabetes.

13 apeutic strategies targeting klotho to treat hematopoietic disorders associated with aging.

14 Transfusion medicine and treatments of hematopoietic disorders associated with severe thrombocy

15 normal female genomic DNAs, and in 12 clonal hematopoietic disorder cDNAs, confirming assay validity.

16 Cyclic neutropenia (CN) is a congenital hematopoietic disorder characterized by remarkably regul

17 king interleukin-2 (IL-2) developed a severe hematopoietic disorder characterized by the abnormal dev

18 These included genes in familial hematopoietic disorders (GATA2, RUNX1), telomeropathies

19 or therapeutic intervention in metabolic and hematopoietic disorders has been hampered by the relativ

20 signaling regulation is involved in various hematopoietic disorders; however, the detailed mechanism

21 Acute myeloid leukemia (AML) is a hematopoietic disorder initiated by the leukemogenic tra

22 o retrovirus-mediated gene therapy for human hematopoietic disorders is the low efficiency of gene tr

23 is a promising strategy to treat congenital hematopoietic disorders, levels of engraftment have not

24 erapy is a promising method for treatment of hematopoietic disorders, neurodegenerative diseases, dia

25 ytic leukemia (JMML) is a unique, aggressive hematopoietic disorder of infancy/early childhood caused

26 o 78.8 kg with acquired or congenital lympho-hematopoietic disorders or metabolic disease.

27 stacles for effective human gene therapy for hematopoietic disorders remains the achievement of an ad

28 regulated tyrosine kinase selectively causes hematopoietic disorders resembling human leukemias in an

29 This review focuses on hematopoietic disorders that are associated with mutatio

30 Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders that are more common in patients

31 gly viewed as a disease spectrum, comprising hematopoietic disorders that extend across a phenotypic

32 l hemoglobinuria (PNH) is an acquired clonal hematopoietic disorder with increased mortality and morb

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。